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Abstract
Human natural killer (NK) cells are central in immune defense with their ability to lyse tumor
cells, and virally infected cells. Increases in tumor formation and viral infection may occur if NK
cytotoxic function is disrupted. Ziram (zinc dithiocarbamate) is used as an accelerating agent in
the production of latex and to protect various fruits and vegetables from fungal infection.
Previously, we have shown that exposure to ziram inhibits NK lytic function. Butyltin (BT)
environmental contaminants, which also inhibit NK lytic function, cause rapid activations of
mitogen activated protein kinases (MAPKs) and decreases in expression of the cytolytic proteins
granzyme B and perforin (after 24 h) in exposed NK cells. MAPKs are important regulators of the
lytic response of NK cells and spurious activation of these enzymes by contaminants would leave
the NK cells unable to respond to appropriate targets. This study examined effects of ziram
exposures on MAPKs (p44/42, p38, and JNK) and on levels of cytolytic proteins. Ten minute to 6
hour exposures of NK cells to ziram caused activation of MAPKs, p44/42 and p38. Exposure to
ziram for 24 h caused a decrease in granzyme B and perforin levels. MAPK inhibitors were able to
prevent these ziram-induced decreases in granzyme B and perforin. These results suggest that
ziram-induced MAPK activation is at least in part responsible for decreased cytolytic function in
ziram-exposed NK cells. Further, the results indicate that these changes are in common with other
environmental contaminants that have been shown to decrease NK lytic function.
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INTRODUCTION
Ziram is a dithiocarbamate used to treat a variety of fungal diseases in crops around the
world such as potatoes, nuts, some fruits, and grain (Caldas et al., 2001). It is also used as an
accelerating agent in the production of latex rubber (DeJong et al., 2002). Humans may be
exposed to ziram by coming into contact with latex or ingesting treated crops (Caldas et al.,
2001; Nettis et al., 2002). It has been shown to cause contact sensitivity in murine local
lymph node assays and health care workers have exhibited positive responses to patch test
(used to determine potential allergic reactions) of a mixture of latex rubber vulcanizing
chemicals including ziram (DeJong et al., 2002). Ziram increases the concanavalin A
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stimulated production of interferon gamma (INF γ) and Interleukin 4 (IL4) in murine
vascular lymph node cells (De Jong et al., 2002).
Natural Killer (NK) cells are lymphocytes that are capable of killing tumor cells, virally
infected cells, and antibody-coated cells. NK cells are responsible for limiting the spread of
blood-borne metastases as well as limiting the development of primary tumors (Lotzova
1993). These cells are the front line of immune response against tumor and virally infected
cells due to their ability to lyse appropriate target cells without prior sensitization (Lotzova
1993; Vivier et al., 2004). Interference with NK cell function by any compound could
increase the risk of viral infection and tumor formation.
A cascade of events is triggered by the binding of target cells to NK cells that leads to the
release of cytotoxic proteins including granzyme B and perforin (housed in granules) from
the NK cells, which lyse the target cells. Upon binding NK-sensitive target cells, non-
receptor protein tyrosine kinases (PTKs) such as Syk, ZAP-70, Src and Pyk2 are activated
(Gismondi et al., 2000). Through a series of signaling steps (Payne et al., 1991; Derijard et
al., 1995; Han et al., 1996), PTK activation ultimately results in activation of mitogen-
activated protein kinases (MAPKs) p44/42, p38, and JNK (Vivier et al.2004). Activation of
MAPKs appears to be in part responsible for the release of cytotoxic granules as well as
other regulatory aspects of NK cells (Trotta et al, 1998, Trotta et al., 2000, Wei et al., 1998).
It has been shown that even brief exposure of human NK cells to the environmental
contaminants, tributyltin (TBT) and dibutyltin (DBT) induced irreversible inhibition of the
ability of NK cells to destroy tumor targets (lytic function) (Whalen et al., 1999, 2002a,
2002b, Dudimah et al., 2007a, 2007b). This loss of lytic function is accompanied decreased
expression of the cytolytic proteins perforin and granzyme (Thomas et al., 2004). TBT and
DBT also activate MAPKs in NK cells (Aluoch and Whalen 2005; Aluoch et al., 2006;
Aluoch et al., 2007; Odman-Ghazi et al., 2010).
Our previous studies have shown that purified NK cells treated with certain concentrations
of ziram are less efficient at killing tumor cells (K562) (Wilson et al., 2004; Whalen et al.,
2003). Ziram is effective in blocking the lytic function of highly purified NK cells at
concentration as low as 125 nM and these effects increase with time (Wilson et al., 2004;
Taylor et al., 2005). Importantly, it was also shown that a brief, 1 h, exposure to ziram
ranging from 10-0.5 µM caused a persistent loss of lytic function when the cells were given
as long as 6 days in ziram-free media before testing for lytic function (Taylor et al., 2005).
Based on the past studies showing that the most rapid consequence of exposures to TBT and
DBT was activation of MAPKs (Aluoch and Whalen 2005; Aluoch et al., 2006; Aluoch et
al., 2007; Odman-Ghazi et al., 2010), the current study examined the effects of ziram
exposures (that lead to loss of lytic function) (Whalen et al., 2003; Wilson et al., 2004;
Taylor et al., 2005) for their ability to alter the activation state of MAPKs in NK cells. NK
cells were exposed to 10-0.5 µM Ziram for 10 min, 1 h, and 6 h and then monitored for
MAPK activation. Concentrations of 10-2.5 µM ziram have previously been shown to cause
a loss of NK lytic function following a 1 h exposure (Whalen et al., 2003; Taylor et al.,
2005). Again, based on the effects seen with TBT and DBT, this study examined the NK
cytotoxic granule proteins, granzyme B and perforin, to determine if their levels were
decreased by exposure to ziram at concentrations and lengths of exposure known to decrease
NK lytic function (Whalen et al., 2003; Taylor et al., 2005).
Taylor and Whalen Page 2














Isolation of NK cells
Peripheral blood from healthy adult volunteer donors was used for this study. Blood samples
(buffy coats) were obtained from a donation facility (American Red Cross, Portland or and
Key Biologics, Memphis, TN). Highly purified NK cells were obtained using a rossetting
procedure. Buffy coats were mixed with 0.6– 0.8 mL of RossetteSepTM human NK cell
enrichment antibody cocktail (Stem Cell Technologies, Vancouver, British Colombia, and
Canada) per 45 mL of buffy coat. The mixture was incubated for 25 min at room
temperature with periodic mixing. Following the incubation, 6–9 mL of the mixture was
layered onto 4 mL Ficoll-Hypaque (1.077 g/mL; Sigma, St. Louis, ML, USA) and
centrifuged at 1200g for 20 min. The cell layer was collected and washed twice with
phosphate buffered saline, pH 7.2 (PBS) and stored in complete media (RPMI-1640
supplemented with 10% heat-activated BCS, 2mM L-glutamine and 50 U penicillin G with
50 µg streptomycin/ml) at 1×106 cells/mL (Whalen et al., 2002b). The resulting cell
preparation was >95% CD16+ and 0% CD3+ according to fluorescence microscopy
Chemical Preparation
Ziram was purchased from Wako Pure Chemicals Industries Limited (Osaka, Japan).
Dimethylsulfoxide (DMSO) was obtained from Sigma-Aldrich (St. Louis, MO USA). A
stock solutions of the compound was made in DMSO. Ziram was diluted in media to
achieve the desired concentrations so that the final concentrations of DMSO did not exceed
0.01%.
Cell Treatment
NK cells (at a concentration of 1.5 million cells/ mL) were exposed in the following ways. 1.
Ziram for 10 minutes: Cells were treated with the appropriate control or 10, 5, 2.5, 1, and 0.5
µM Ziram for 10 min at 37°C, 5%CO2. 2. Ziram for 1 hour: Cells were treated with the
appropriate control or 10, 5, 2.5, 1, and 0.5 µM Ziram for 1 h at 37°C, 5%CO2. 3. Ziram for
6 hours: Cells were treated with the appropriate control or 10, 5, 2.5, 1, and 0.5 µM Ziram
for 6 h at 37°C, 5%CO2. 3. Ziram for 24 hours: Cells were treated with the appropriate
control or 2.5, 1, and 0.5 µM Ziram for 24 h at 37°C, 5%CO2. Following the above
incubations the cells were washed twice and then lysed as described below.
Cell Viability
Cell viability was determined by trypan blue exclusion (Whalen et al., 2003). Cell number
and viability, assessed at the beginning and end of each exposure period, did not vary
significantly among the control cells and experimental conditions for any of the
concentrations tested.
Cell Lysates
Cell lysates were made using NK cells treated as described in the cell treatment section.
Following the above treatments, the cells were centrifuged and the cell pellets were lysed
using 500 µL of lysis buffer (Active motif, Carlsbad, CA) per 10 million cells. The cell
lysates were stored frozen at −80°C up to the point when they were run on SDS-PAGE. All
controls and Ziram-exposed cells for a given experimental set-up (described above) were
from an individual donor. Each of the experimental set-ups was repeated a minimum of
three times using cells from different donors.
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Cell lysates were run on 10% sodium dodecylsulfate polyacrylamide gel electrophoresis
(SDS-PAGE) and transferred to polyvinylidene difluoride (PVDF) membrane. The PVDF
was immunoblotted with anti-phospho-p38 (Thr180 and Tyr182), anti-p38, anti-phospho-
p44/42 (Thr202/Tyr204), anti-p44/42, anti-phospho-JNK, anti-JNK, and anti-β-actin
antibodies (Cell Signaling Technologies, Beverly, MA). Antibodies were visualized using
ECL chemiluminescent detection system (Amersham, Piscataway, NJ) and Kodak Image
Station (Kodak, Rochester, NY). The density of each protein band was determined by
densitometric analysis using the Kodak Image Station analysis software. The settings on the
image station were optimized to detect the largest possible signal range and to prevent
saturation of the system. Samples from all the experimental setups (listed in the cell
treatment section) were run on a separate gel/blot. A given experimental set-up (as described
in the cell treatment section) always had its own internal control. Thus, changes in protein
expression were determined relative to the internal control. This determination provided
relative quantitation by evaluating whether a given treatment changed expression of the
specified protein relative to untreated cells. β-actin levels were determined for each
condition to verify that equal amounts of protein were loaded. In addition, the density of
each protein band was normalized to β-actin to correct for small differences in protein
loading among the lanes.
Statistical analysis
Statistical analysis of the data for western blot analyses was carried out using ANOVA
followed by pair-wise comparison using Student’s t test. A minimum of three separate
determinations were carried out for each experimental set-up (n≥3) and statistical
significance was noted at p<0.05.
RESULTS
Effects of 10 minute exposures to ziram on MAPKs in NK cells
Figure 1 A and B show the effects of 10 minute exposures to 10 µM, 5 µM, 2.5 µM, 1 µM,
and 0.5 µM ziram on p44/42. 10 minute exposures to 10 µM ziram caused a 3 fold increase
in phosphorylation of p44/42(p<0.05) and 10 minute exposures to 5 µM ziram caused a 2
fold increase in phosphorylation of p44/42 (p<0.05). 10 minute exposures to 2.5 µM, 1 µM,
and 0.5 µM ziram caused no significant increase in phosphorylation of p44/42(p>0.05). The
total level of p44/42 was not affected by exposure to ziram (Figure 1A and B). 10 minute
exposures to 10 µM ziram caused a 3 fold increase in phosphorylation of p38 (p<0.05),
while exposures to 5 µM and 2.5 µM ziram caused 2 fold increases in phosphorylation of
p38 (p<0.05) (Figure 2A and B). There were no significant changes in either phosphorylated
or total JNK (Figure 2C, representative experiment).
Effects of 1 h exposure to ziram on NK cell MAPKs
Effects of 1 h exposures to ziram on p44/42 are shown in Figure 3A and B. 1 h exposures to
10 µM and 5 µM ziram always caused increases in phosphorylation of p44/42 in each of the
experiments carried out (a minimum of 3 separate experiments). The increases seen at 10
µM ranged from 2.5 fold to 10 fold while those seen at 5 µM ranged from 2 fold to 20 fold.
However, the variability in fold increase was such that when the data was combined the
increases gave a p value greater than 0.05. 1 h exposures to 2.5 µM ziram caused a 3 fold
increase in phosphorylation of p44/42 which was statistically significant (p<0.05), while 1 h
exposures to 1 µM and 0.5 µM ziram caused no significant change in phosphorylation of
p44/42 (p>0.05). Effects of 1h exposures to 10 µM, 5 µM, 2.5 µM, 1 µM, and 0.5 µM ziram
on p38 are shown in Figure 4A and B. 1 h exposures to 10 µM and 5 µM ziram caused
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increases in p38 phosphorylation in every experiment. The fold increases seen with 10 µM
ziram were 1.8 to 4.3 fold and at 5 µM were 1.8–2.9 fold. At these concentrations, the p-
value was greater than 0.05 when all experiments were combined due to the variability in
the fold increases. A 1 h exposure to 2.5 µM ziram caused a very reproducible 2 fold
increase in p38 phosphorylation (p<0.05) and a 1 h exposure to 1 µM, and 0.5 µM ziram
caused no significant increase in p38 phosphorylation (p>0.05). As was seen after a 10 min
exposure to ziram, there were no significant changes in either phosphorylated or total JNK
with 1 h exposures to ziram (data not shown)
Effects of 6 h exposure to ziram on NK cell MAPKs
Figure 5A and B show the effects of 6 h exposures to 10 µM, 5 µM, 2.5 µM, 1 µM, and 0.5
µM ziram on p44/42. 6 h exposures to 10 µM ziram caused increases in phosphorylation of
p44/42 that ranged from 1.4 to 9.7 fold while increases in phosphorylation of 4 to 13 fold
were seen when NK cells were exposed to 5 µM ziram. As was seen with the 1 h exposure at
these concentrations of ziram, the variability was such that when data from replicate
experiments were combined the p value exceeded 0.05. A 6 h exposure to 2.5 µM ziram
caused a 23 fold increase in phosphorylation of p44/42 (p<0.05). A 6 h exposure to 10 µM,
5 µM, 2.5 µM, 1 µM, and 0.5 µM ziram caused no statistically significant increase in p38
phosphorylation (data not shown). Again, there were no significant changes in either
phosphorylated or total JNK after 6 h exposures to ziram (data not shown).
Effects of ziram on NK cell cytolytic proteins
Effects of 2.5 µM, 1 µM, and 0.5 µM ziram on levels of granzyme B and perforin are shown
in figure 6A and B. A 24 h exposure to 2.5 µM ziram caused a 51% decrease in granzyme
levels (P<0.05) while 24 h exposure to 1 µM and 0.5 µM ziram caused no decreases in NK
cell granzyme levels. A 24 h exposure to 2.5 µM ziram caused a 70% decrease perforin
levels (P<0.05) a 24 h exposure to 1 µM and 0.5 µM ziram caused no significant decreases
in NK cell perforin.
Effects of inhibitors of p44/42 and p38 activation on the decreases in cytolytic proteins
seen with 2.5 µM ziram
In order to examine whether there was a role for the ziram-induced activation of either
p44/42 or p38 in the decreases in granzyme and perforin seen with ziram treatments, we
carried out experiments using specific inhibitors of each enzyme. NK cells were treated with
2.5 µM ziram which reliably decreased both granzyme and perforin levels in NK cells after
a 24 h exposure. NK cells that were pretreated for 1 h with either 50 mM SB202190 (a
selective inhibitor of p38 activation) or 50 mM PD98059 (a selective inhibitor of p44/42
activation) or with control media were then exposed to either control or 2.5 µM ziram for 24
h. The cells were examined for levels of granzyme and perforin using western blot. Figures
7A and 7B show that cells pretreated with SB202190 for 1 h prior to a 24 h exposure to 2.5
µM ziram showed only a slight decrease in granzyme compared to control cells. Thus,
inhibition of p38 activation is able to prevent nearly all of the loss of granzyme B that is
induced by a 24h exposure to 2.5 µM ziram. However, SB202190 was unable to block the
ziram-induced decrease in perforin. Conversely, inhibition of p44/42 by PD98059 was able
to block the ziram-induced decrease in perforin but had no effect on ziram-induced
decreases in granzyme B (Figures 7C and 7D).
DISCUSSION
Earlier studies have shown that ziram exposures decrease the lytic function of NK cells
(Taylor et al., 2005; Wilson et al., 2004; Whalen et al., 2003). A brief (1h) exposure to ziram
induces decreases in lytic function that can persist for at least 6 days in ziram-free media
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(Taylor et al., 2005). Ziram is not considered mutagenic (Franekic et al., 1994; Zenzen et al.,
2001), however, chromosomal changes have been seen in workers exposed to ziram for 3–5
years, indicating some risk of mutations (Edwards et al., 1991). There do not appear to be
any studies examining the levels of ziram in human blood. Ziram’s ability to inhibit NK
cells (Whalen et al., 2003; Wilson et al., 2004; Taylor et al., 2005), which are involved in
preventing tumor formation, may classify it as a promoter of increased cancer risk.
Examining the effects of this compound on human NK function is valuable for those who
work in the industry of producing this compound, those in agriculture using it as a fungicide
and individuals that may live near fields that have been treated with ziram.
The purpose of the current study was to examine the effects of ziram on the activation state
of MAPKs in NK cells as well as NK cytolytic protein levels. NK cells were treated with
levels of the compounds that have previously been shown to cause a loss of NK function
following a 1 h exposure. As blood levels of ziram in humans have not been measured, it is
hard to know if the levels at which we see effects would be experienced in exposed
individuals. Exposures to another category of environmental contaminant, butyltins (BTs),
have been shown to activate MAPKs (Aluoch and Whalen, 2005; Aluoch et al., 2006;
Aluoch et al., 2007; Odman-Ghazi et al., 2010) at levels that have been measured in human
blood samples (Whalen et al., 1999; Kanan et al, 1999). As many of the other changes seen
in NK cells with exposures to BTs, such as persistent loss of NK function with a brief
exposure to the compounds and decreased cell-surface protein expression (Whalen et al.,
2002; Odman-Ghazi et al., 2003; Dudimah et al., 2007a, b), were also seen with ziram
exposures (Wilson et al., 2004; Taylor et al., 2005; Taylor and Whalen, 2009), we examined
ziram’s ability to activate MAPKs. Exposures as brief as 10 min showed significant
increases in activating phosphorylation of the MAPKs (p44/42 and p38). Overall there was
an increase in MAPK activation with dose as well as with time. As was noted in the results
section, higher concentrations of ziram (10 µM, and 5 µM) caused increases in activations of
p44/42 and p38 which were on average greater at 1 h than those seen at 10 min. However,
they were not statistically significant due to the high variability of the increases seen from
one experiment to the next. This was also true after a 6 h exposure for p44/42. However, a
six hour exposure to 2.5 µM ziram caused a dramatic 23 fold increase in p44/42
phosphorylation, which was much greater than that seen at 10 or 5 µM.
It is of interest that the activation of both p44/42 and p38 seen at higher concentrations (10
and 5 µM) of ziram for 1 h was highly variable but became stable at 2.5 µM. It is possible
that when there is such a large activation of the MAPKs at 10 and 5µM that this may induce
a feedback inhibitory process attempting to inhibit their activation and leading to significant
variability in the measurable activation. The stability of the more moderate activation seen at
2.5 µM may be due to that fact that this level of activation doesn’t cause as robust an
activation of this turn-off mechanism . It has been shown (in other mammalian cells) that
activation of p38 induces the production of MAPK phosphatase-1 (Staples et al., 2010)
which is capable of dephosphorylating and thus inactivating both p44/42 and p38 MAPKs
(Dickinson and Keyse, 2006). It is possible that such a p38 induced activation of an MKP-1
may be occurring in NK cells and is an area for further study. It was also possible that NK
cell death was occurring at the higher concentrations of Ziram at 1 h and 6 h and thus
causing the increased variability in the activations of MAPKs. However, we examined the
viability of the NK cells under these conditions and it was not decreased compared to
control cells (materials and methods section).
The release of NK cytolytic granules and thus the cytolytic process is in part regulated by
MAPKs (Trotta et al, 1998, Trotta et al., 2000, Wei et al., 1998). In normally functioning
NK cells, the binding of a target cell will stimulate activation of MAPKs. Exposure of NK
cells to ziram activates the p44/42 and p38 MAPKs. The activation of these MAPKs by
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ziram would then leave the NK cell unable to activate MAPKs in response to target binding
as these enzymes would have already been activated by the Ziram exposure and are no
longer available to be activated by the target cell’s binding. We have shown that premature
activation of p44/42 by phorbol 12-myristate 13-acetate (PMA) leads to inhibition of NK
lytic function (Dudimah et al., 2010). Compounds that activate p44/42 to a similar extent to
that seen with PMA inhibit NK lytic function to a similar extent (Dudimah et al., 2010).
Previously, we have shown that tributyltin (TBT) was able to activate p44/42, p38, and JNK
MAPKs (Aluoch et al., 2006; Aluoch et al., 2007) while dibutyltin (DBT) activated only
p44/42 and p38 but not JNK (Odman-Ghazi et al., 2010). The fact that ziram activated only
p44/42 and p38 was similar to the results seen with DBT. However, the fold activation seen
with Ziram at 10 and 5 µM is greater than that seen with DBT at the same concentrations
and lengths of exposure. All three compounds share the ability to activate NK-cell MAPKs
however, the pattern and intensity of activation varies depending on the compound. The
shared target of MAPKs among these three different compounds may indicate that the
MAPK signaling pathway in NK cell (which is known to regulate NK responsiveness) is
particularly vulnerable to an array of environmental contaminants.
The current study examined ziram effects on NK cell cytolytic proteins, showing that a 24 h
exposure to 2.5 µM ziram caused decreases in granzyme B levels and perforin levels. These
decreases would also diminish the capacity of the NK cells to respond to target cells. These
results are similar to what has been found with TBT (Thomas et al., 2004) and DBT (Caltin
et al., 2005). NK cytolytic protein levels appear to be at least in part regulated by the MAPK
dependent transcription regulator AP-1 (Hanson et al., 1993) and thus, the decrease in their
expression with longer ziram exposures may be a result of the ziram-induced dysregulation
of MAPKs. We investigated this possibility by exposing NK cells to ziram in the presence
of an inhibitor that prevents p44/42 activation (PD98059) as well as an inhibitor that
prevents p38 activation to see if inhibiting ziram-induced p44/42 or p38 activation could
prevent ziram induced decreases in granzyme and perforin. The inhibitors were used at
concentrations that prevent activation of these MAPKs in NK cells (Abraha et al. 2009). The
results showed that activation of p38 by ziram is needed for ziram-induced losses of
granzyme B, while p44/42 activation appears to be needed for ziram–induced decreases in
perforin. These data show direct involvement of each of the MAPKs that are activated by
ziram exposure in the loss of cytolytic proteins seen with ziram.
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Effects of 10 minute exposures to 10-0.5 µM Ziram on phospho-p44/42 and total p44/42 in
NK cells: A) levels of phospho-p44/42 and total p44/42 normalized to control in pure NK.
Values are mean ± S.D. from at least three separate experiments using cells from different
donors. * indicates significant difference compared to the control (p<0.05). β-actin levels
were determined for each condition to verify that equal amounts of protein were loaded. In
addition, the density of each protein band was normalized to β-actin to correct for small
differences in protein loading among the lanes. B) Blot from a representative experiment.
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Effects of 10 minute exposures to 10-0.5 µM Ziram on phospho-p38 and total p38 and
phospho-JNK and total JNK in NK cells: A) levels of phospho-p38 and total p38 normalized
to control in pure NK. Values are mean ± S.D. from at least three separate experiments using
cells from different donors. * indicates significant difference compared to the control
(p<0.05). B) Blot from a representative experiment for phospho-p38 and total p38. C) Blot
from a representative experiment for phospho-JNK and total JNK.
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Effects of 1 hour exposures to 10-0.5 µM Ziram on phospho-p44/42 and total p44/42 in NK
cells: A) levels of phospho-p44/42 and total p44/42 normalized to control in pure NK.
Values are mean ± S.D. from at least three separate experiments using cells from different
donors. * indicates significant difference compared to the control (p<0.05). B) Blot from a
representative experiment.
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Effects of 1 hour exposures to 10-0.5µM Ziram on phospho-p38 and total p38 in NK cells:
A) levels of phospho-p38 and total p38 normalized to control in pure NK. Values are mean
± S.D. from at least three separate experiments using cells from different donors. * indicates
significant difference compared to the control (p<0.05). B) Blot from a representative
experiment.
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Effects of 6 hour exposures to 10-0.5 µM Ziram on phospho-p44/42 and total p44/42 in NK
cells: A) levels of phospho-p44/42 and total p44/42 normalized to control in pure NK.
Values are mean ± S.D. from at least three separate experiments using cells from different
donors. * indicates significant difference compared to the control (p<0.05). B) Blot from a
representative experiment.
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Effects of 24 hour exposures to 2.5-0.5 µM Ziram on levels of granzyme B and perforin in
NK cells: A) levels of granzyme B and perforin normalized to control in pure NK. Values
are mean ± S.D. from at least three separate experiments using cells from different donors. *
indicates significant difference compared to the control (p<0.05). B) Blots from a
representative experiment.
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p38 inhibitor, SB202190, reverses ziram-induced granzyme B decreases and the p44/42
inhibitor, PD98059, reverses ziram-induced perforin decreases in NK cells: A) levels of
granzyme B in cells exposed to 2.5 µM ziram in the presence and absence of the p38
inhibitor, SB202190. Values are mean ± S.D. from three separate experiments using cells
from different donors. * indicates significant difference compared to the cells treated with
ziram in the presence of SB202190 (p<0.05). B) Blots from a representative experiment. C)
levels of perforin in cells exposed to 2.5 µM ziram in the presence and absence of the
p44/42 inhibitor, PD98059 . Values are mean ± S.D. from three separate experiments using
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cells from different donors. * indicates significant difference compared to the cells treated
with ziram in the presence of PD98059 (p<0.05). D) Blots from a representative experiment.
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